“What is this previously scheduled DSMC meeting? In Brazil?”
There was a scheduled interim analysis for both COVID trials. I believe it was 50 patients or so for the severe trial. At 50 patients, the DSMC reviews basic data from the trial and makes a recommendation to stop, continue or change the trial. Based on the U.S. trials, I assume the DSMC will recommend to continue the trial as planned.
“CytoDyn is committed to FDA compliance,” said Scott A. Kelly
Is Pausing Brazil trials a way of showing compliance to FDA? Some sort of implicit head-nod between fda and company, as an extension to the covid hold in US. Or something completely independent?
Check out the mortality percentages of those who are vaccinated, who have CoVID that die. Less than 3 out of 100,000 people. Although we don’t want to see anyone die from this insidious virus, the powers that be believe well less than 1 % is an acceptable mortality level. I repeat, COVID IS OVER FOR CYDY. I Called this 6 months ago. Cytodyn and “longs” are just getting the message.
News 
Market Data 
Discover 
